Companies
/Healthcare
Omnicell Inc
$36.49
▲ $0.68 (+1.90%) today
Markets closed · 10:45pm ET
OMCL at a Glance
Valuation
- Market cap
- $1.6B
- P/E ratio
- 42.6
Profitability
- Revenue (TTM)
- $1.2B
- Profit margin
- 3.1%
- EPS (TTM)
- $0.84
Price
- 52-week range
- $29 – $55
- Street target
- $57.86
Earnings
- Next report
- Oct 29, 2026
Headquartered in Fort Worth, TX Fiscal year ends December NASDAQ: OMCL omnicell.com
About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a healthcare technology company focused on intelligent medication management. Since 1992, Omnicell has delivered pharmacy and nursing solutions across all settings of care, unifying automation and AI-enabled intelligence with expert services to drive clinical and business outcomes. The company's portfolio includes connected medication dispensing devices, software solutions, SaaS offerings, technical services, consumables, and specialty pharmacy services including 340B program support. Its next-generation platforms, Omnicell Titan XT and OmniSphere, are designed to provide enterprise-wide visibility, automation, and intelligence across medication workflows. Omnicell serves healthcare facilities worldwide, helping them improve operational efficiency, medication safety, and workforce productivity. The company generates revenue through product sales (connected devices and software licenses), technical services, SaaS and Expert Services, and consumables. Updated
Frequently Asked Questions
What does Omnicell do?
Omnicell, Inc. (NASDAQ: OMCL) is a healthcare technology company focused on intelligent medication management. Since 1992, Omnicell has delivered pharmacy and nursing solutions across all settings of care, unifying automation and AI-enabled intelligence with expert services to drive clinical and business outcomes.
What is the OMCL stock price target?
The Wall Street consensus 12-month price target for OMCL is $57.86.